Carcinogenesis, Vol. 20, No. 2, 193-198,
February 1999
© 1999 Oxford University Press
Defining the substrate specificity of cdk4 kinase–cyclin D1 complex
Genetics and Cancer Group, Dupont Pharmaceutical Co., Experimental Station E336/207, Wilmington, DE 19880-0336, USA
cdk4 kinase–cyclin D1 complex (cdk4/D1) does not phosphorylate all of the sites within retinoblastoma protein (Rb) equally. Comparison of five phosphorylation sites within the 15 kDa C domain of Rb indicates that Ser795 is the preferred site of phosphorylation by cdk4/D1. A series of experiments has been performed to determine the properties of this site that direct preferential phosphorylation. For cdk4/D1, the preferred amino acid at the third position C-terminal to the phosphorylated serine/threonine is arginine. Substitution of other amino acids, including a conservative change to lysine, has dramatic effects on the rates of phosphorylation. This information has been used to mutate less favorable sites in Rb, converting them to sites that are now preferentially phosphorylated by cdk4/D1. A conserved site at Ser842 in the related pocket protein p107 is also preferentially phosphorylated by cdk4/D1. Although Rb and p107 differ significantly in sequence, the Rb Ser795 site can replace the p107 Ser842 site without affecting the rate of phosphorylation. These results suggest that although a determinant of specificity resides in the sequences surrounding the phosphorylated site, the structural context of the site is also a critical parameter of specificity.
Abbreviations: BSA, bovine serum albumin; cdk, cyclin-dependent kinase; cdk4/D1, cdk4 kinase–cyclin D1 complex; DTT, dithiothreitol; GST, glutathione S-transferase; Rb, retinoblastoma protein.
1 To whom correspondence should be addressed Email: robert.h.grafstrom{at}dupontpharma.com
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. J. Day, A. Cleasby, I. J. Tickle, M. O'Reilly, J. E. Coyle, F. P. Holding, R. L. McMenamin, J. Yon, R. Chopra, C. Lengauer, et al. Crystal structure of human CDK4 in complex with a D-type cyclin PNAS, March 17, 2009; 106(11): 4166 - 4170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Huynh, K. C. Soo, P. K.H. Chow, L. Panasci, and E. Tran Xenografts of Human Hepatocellular Carcinoma: A Useful Model for Testing Drugs. Clin. Cancer Res., July 15, 2006; 12(14): 4306 - 4314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wallace and K. L. Ball Docking-Dependent Regulation of the Rb Tumor Suppressor Protein by Cdk4 Mol. Cell. Biol., June 15, 2004; 24(12): 5606 - 5619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Benzeno, G. Narla, J. Allina, G. Z. Cheng, H. L. Reeves, M. S. Banck, J. A. Odin, J. A. Diehl, D. Germain, and S. L. Friedman Cyclin-Dependent Kinase Inhibition by the KLF6 Tumor Suppressor Protein through Interaction with Cyclin D1 Cancer Res., June 1, 2004; 64(11): 3885 - 3891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Schroeder, J. Symowicz, and L. A. Schuler PRL Modulates Cell Cycle Regulators in Mammary Tumor Epithelial Cells Mol. Endocrinol., January 1, 2002; 16(1): 45 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Nelsen, D. G. Rickheim, N. A. Timchenko, M. W. Stanley, and J. H. Albrecht Transient Expression of Cyclin D1 Is Sufficient to Promote Hepatocyte Replication and Liver Growth in Vivo Cancer Res., December 1, 2001; 61(23): 8564 - 8568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Pan, S. Cox, R. H. Hoess, and R. H. Grafström A Cyclin D1/Cyclin-dependent Kinase 4 Binding Site within the C Domain of the Retinoblastoma Protein Cancer Res., April 1, 2001; 61(7): 2885 - 2891. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Soni, T. O'Reilly, P. Furet, L. Muller, C. Stephan, S. Zumstein-Mecker, H. Fretz, D. Fabbro, and B. Chaudhuri Selective In Vivo and In Vitro Effects of a Small Molecule Inhibitor of Cyclin-Dependent Kinase 4 J Natl Cancer Inst, March 21, 2001; 93(6): 436 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. V. Finkielstein, A. L. Lewellyn, and J. L. Maller The midblastula transition in Xenopus embryos activates multiple pathways to prevent apoptosis in response to DNA damage PNAS, January 30, 2001; 98(3): 1006 - 1011. [Abstract] [Full Text] [PDF]
|
|